SCHEMBL17142140

SCHEMBL17142140

N#Cc1cccc(C(=O)NCc2ccccc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 1/20 0.64
HDAC8 Q9BY41 1/20 0.64
HDAC6 Q9UBN7 1/20 0.64
MAOA P21397 2/20 0.60
CHRM3 P20309 1/20 0.60
VNN1 O95497 1/20 0.60
GPR139 Q6DWJ6 1/20 0.57
ALDH1A1 P00352 2/20 0.57
GAA P10253 1/20 0.57
HSD17B10 Q99714 1/20 0.57
CFD P00746 1/20 0.57
HTT P42858 3/20 0.56
PPARG P37231 1/20 0.56
EPHX2 P34913 1/20 0.55
NR1H4 Q96RI1 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 1/20 0.54
POLB P06746 1/20 0.54
ALOX12 P18054 1/20 0.54
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9365904 0.91 MAOA (0.66) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL28146231 0.89 CHRM3 (0.55) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL5094235 0.88 ROCK2 (0.59) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL22304851 0.88 HDAC2 (0.59) HDAC2HDAC8HDAC6MAOAALDH1A1
SCHEMBL6237491 0.88 EPHX2 (0.54) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL5091359 0.87 CHRM3 (0.54) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL7233161 0.87 CHRM3 (0.54) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL7985996 0.86 GAA (0.56) CHRM3VNN1ALDH1A1GAAHTT
SCHEMBL7989764 0.86 GAA (0.53) HDAC2HDAC8HDAC6MAOACHRM3
SCHEMBL8360303 0.85 HDAC6 (0.57) HDAC2HDAC8HDAC6MAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170137413-A1 NOVEL HALOGEN-SUBSTITUTED COMPOUNDS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-18 US disclosed
EP-3126353-A1 NOVEL 3-[(PYRAZOL-5-YL)-HETEROARYL]-BENZAMIDE DERIVATIVES AND USE THEREOF AS PEST CONTROL AGENTS Bayer CropScience Aktiengesellschaft (DE) 2017-02-08 EP disclosed
WO-2015150442-A1 NOVEL 3-[(PYRAZOL-5-YL)-HETEROARYL]-BENZAMIDE DERIVATIVES AND USE THEREOF AS PEST CONTROL AGENTS BAYER CROPSCIENCE AG (DE) 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170137413-A1 NOVEL HALOGEN-SUBSTITUTED COMPOUNDS CYP4F3, PYM1, PRDX4 HDAC2 2780/4885HDAC8 4268/4885HDAC6 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.